NASDAQ: CYANCyanotech Corp Stock
$1.00+0.02 (+2.04%)
Updated Mar 17, 2023
CYAN Price
$1.00
Fair Value Price
$1.42
Market Cap
$6.27M
52 Week Low
$0.90
52 Week High
$3.62
P/E
-3.45x
P/B
0.35x
P/S
0.27x
PEG
N/A
Dividend Yield
N/A
Revenue
$25.91M
Earnings
-$1.73M
Gross Margin
33.8%
Operating Margin
-5.02%
Profit Margin
-6.7%
Debt to Equity
0.68
Operating Cash Flow
-$2M
Beta
0.14
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CYAN Overview
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company's products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant to enhance skin, and to support eye, joint and immune health, as well as used as a human dietary supplement and dietary ingredient; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. It also provides contract extraction services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health foods, nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
Zen Score
–
Industry Average (34)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CYAN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CYAN ($1.00) is undervalued by 29.56% relative to our estimate of its Fair Value price of $1.42 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CYAN ($1.00) is significantly undervalued by 29.56% relative to our estimate of its Fair Value price of $1.42 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
CYAN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CYAN due diligence checks available for Premium users.
Be the first to know about important CYAN news, forecast changes, insider trades & much more!
CYAN News
Valuation
CYAN fair value
Fair Value of CYAN stock based on Discounted Cash Flow (DCF)
Price
$1.00
Fair Value
$1.42
Undervalued by
29.56%
CYAN ($1.00) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CYAN ($1.00) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CYAN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CYAN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-3.45x
Industry
18.97x
Market
21.81x
CYAN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.35x
Industry
2.29x
CYAN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CYAN's financial health
Profit margin
Revenue
$5.9M
Net Income
-$598.0k
Profit Margin
-10.2%
CYAN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CYAN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$29.8M
Liabilities
$12.0M
Debt to equity
0.68
CYAN's short-term assets ($14.53M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CYAN's short-term assets ($14.53M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CYAN's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CYAN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$223.0k
Investing
-$328.0k
Financing
$685.0k
CYAN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CYAN vs Food Stocks
Cyanotech Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.